| 000 | 01691 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517010250.0 | ||
| 264 | 0 | _c20151026 | |
| 008 | 201510s 0 0 eng d | ||
| 022 | _a1432-0711 | ||
| 024 | 7 |
_a10.1007/s00404-014-3593-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYıldırım, Aysegul | |
| 245 | 0 | 0 |
_aEarly prediction for the requirement of second or third dose methotrexate in women with ectopic pregnancy, treated with single-dose regimen. _h[electronic resource] |
| 260 |
_bArchives of gynecology and obstetrics _cJun 2015 |
||
| 300 |
_a1327-32 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAbortifacient Agents, Nonsteroidal _xadministration & dosage |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 |
_aChorionic Gonadotropin, beta Subunit, Human _xblood |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMethotrexate _xadministration & dosage |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 |
_aPregnancy, Ectopic _xblood |
| 650 | 0 | 4 | _aProbability |
| 650 | 0 | 4 | _aRegression Analysis |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aUltrasonography |
| 700 | 1 | _aCırık, Derya Akdağ | |
| 700 | 1 | _aAltay, Metin | |
| 700 | 1 | _aGelisen, Orhan | |
| 773 | 0 |
_tArchives of gynecology and obstetrics _gvol. 291 _gno. 6 _gp. 1327-32 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00404-014-3593-x _zAvailable from publisher's website |
| 999 |
_c24465274 _d24465274 |
||